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Background: Low-load, high-repetitive single-limb resistance training may increase limb muscle function and functional
exercise capacity in patients with chronic obstructive pulmonary disease (COPD) while minimizing the occurrence
of limiting exertional symptoms. Whether high-repetitive single-limb resistance training would perform better than
high-repetitive two-limb resistance training is unknown. In addition, the mechanisms underlying possible benefits
of high-repetitive resistance training has not been investigated. The aims of this study are to compare single versus
two-limb high-repetitive resistance training in patients with COPD and to investigate mechanisms of action of
these training modalities.
Methods/Design: This trial is a prospective, assessor-blind, randomized controlled trial. The participants are patients
with stable severe to very severe COPD who are older than 40 years of age and healthy controls. The intervention is
single-limb, high-repetitive, resistance training with elastic bands, three times/week for 8 weeks.
The control is two-limb high-repetitive resistance training with elastic bands, three times/week for 8 weeks.
The primary outcomes is change in the 6-min walking distance after 8 weeks of single-limb or two-limb high-repetitive
resistance training.
The secondary outcomes are changes in limb muscle strength and endurance capacity, key protein involved in
quadriceps anabolic/catabolic signalization, fiber-type distribution and capillarization, subjective dyspnea and muscle
fatigue, muscle oxygenation, cardiorespiratory demand and health-related quality-of-life after 8 weeks of single-limb or
two-limb high-repetitive resistance training.
The acute effects of single-limb versus two-limb high-repetitive resistance training on contractile fatigue, exercise stimulus
(the product of number of repetition and load), subjective dyspnea and muscle fatigue, muscle oxygenation, and
cardiorespiratory demand during upper and lower limb exercises will also be investigated in patients with COPD
and healthy controls.
Randomization will be performed using a random number generator by a person independent of the recruitment
process, using 1:1 allocation to the intervention and the control group using random block sizes.
Blinding: All outcome assessors will be blinded to group assignment.
Discussion: The results of this project will provide important information to help developing and implementing
customized exercise training programs for patients with COPD.
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Randomized controlled trialBackground
The key disabling features in chronic obstructive pul-
monary disease (COPD) include exercise intolerance,
dyspnea and leg fatigue [1-3]. Increased dyspnea during
physical activity is also a major reason for patients seek-
ing medical care and is associated with lower quality of
life [4]. Limb muscle dysfunction is another frequent
manifestation of COPD. Decreased limb muscle strength
and endurance have been documented in this disease
[5,6]. Since limb muscle dysfunction in COPD is strongly
associated with exercise intolerance, improving muscle
function is of upmost importance. Limb muscle weak-
ness is considered as a significant determinant of re-
duced exercise capacity in COPD [6] and is present in
all stages of the disease [7]. As a consequence, most pre-
vious studies on resistance training in patients with
COPD primarily focus on increasing muscle strength,
typically using high loads and low number of repetitions
[6,8]. However, the benefits of this resistance training
strategy on functional capacity (for example, walking)
are small in this group of patients [8]. Since quadriceps
endurance is a determinant of physical activity level [5]
and may be reduced to a larger extent than quadriceps
strength [9,5], the possibility of improving limb muscle
endurance is of interest. To achieve this goal, high-
repetition resistance exercises is recommended [10]. Fur-
thermore, regardless the type of exercise performed,
achieving an optimal exercise stimulus for involved mus-
cles could be challenging in patients with COPD because
ventilatory limitation and dyspnea may occur prior to
contracting muscles being maximally stressed [11,12].
This is of importance because the degree of exercise
stimulus is central to optimize benefits from the exercise
training performed.
Partitioning the exercising muscle mass (that is, exercis-
ing using a single limb at a time) is a novel strategy used
to reduce the extent to which the ventilatory limitation
hinders the ability to reach sufficient exercise stimulus
and to optimize the effects of the exercise training in pa-
tients with COPD [13]. A randomized controlled study
using the concept of partitioning the exercising muscle
mass performed as high-repetitive single-limb resistance
training have recently been conducted by our group [14].
All resistance exercises within this study were executed
with a single limb at a time in order to minimize to loadon the ventilatory system to maximize the muscle-specific
exercise stimulus [15,14]. It was found that 8 weeks of
high-repetitive single-limb resistance training can improve
walking capacity and muscle function while avoiding the
occurrence of limiting exertional symptoms in patients
with moderate to severe COPD [14]. However, since there
was no active comparator, we do not know whether the
single-limb execution of the resistance exercises would be
more beneficial than when involving larger amount of
muscle mass [16,17,14]. It could be anticipated that parti-
tioning the exercising muscle mass during high-repetitive
resistance training would allow the patients to maintain a
high number of repetitions while being able to use higher
loads or higher local training intensities than if a larger
amount of muscle mass would be involved (for example,
exercising with both legs or both arms simultaneously).
Another limitation of our study on high-repetitive
single-limb resistance training is that potential structural
and muscle adaptations could not be confirmed as the
mechanisms underlying the improvements were not
assessed [14]. The impact of high-repetitive resistance
training on muscle fatigue was also not explored. This is
potentially important considering that unpublished data
from our laboratory indicate that high-repetitive single-
leg exercise may induce muscle fatigue in the absence of
muscle deoxygenation, considering that larger training
effects have been shown in patients with COPD who de-
velop quadriceps contractile fatigue during exercise
training [18].
Lastly, the majority of patients included in this previous
research had moderate airflow limitation, whereas high-
repetitive single-limb resistance training would appear
particularly suited for patients with advanced ventilator
limitation. Thus, the overall aim of the current project is
to investigate the muscular and functional effects of high-
repetitive resistance training, in patients with severe to
very severe COPD and to better understand the mecha-
nisms of action of this training modality.Methods/Design
The study is a prospective, assessor-blind, block ran-
domized, controlled, parallel-group trial constructed in
accordance to the consolidate standards of reporting tri-
als guidelines [19,20] (Figure 1). The study contains a
chronic and an acute phase. In the chronic phase, the
benefits of 8 weeks of single-limb and two-limb high-
Figure 1 Consolidate standards of reporting trials (CONSORT) flow diagram of trial design.
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tients with severe and very severe COPD. The acute
phase will be used to investigate, at baseline, the acute
physiological effects of single-limb and two-limb high-
repetitive resistance training in patients with COPD and
also in healthy controls. An overview of the two phases
including a description of the testing procedure can be
seen in Table 1.
Objectives
Primary outcome
The primary outcome is change in the 6-min walking
distance after 8 weeks of single-limb versus two-limb
high-repetitive resistance training.
Secondary outcomes
The secondary outcomes are changes in the following:
1. quadriceps endurance capacity;2. key protein involved in quadriceps anabolic/catabolic
signalization, fiber-type distribution, enzymatic
activities and capillarization;
3. dyspnea and muscle fatigue perception;
4. quadriceps oxygenation;
5. cardiorespiratory response; and
6. health-related quality-of-life, after 8 weeks of
single-limb versus two-limb high-repetitive
resistance training.
Secondary outcomes will also include acute effects of
single-limb versus two-limb high-repetitive resistance
exercises on the following:
1. quadriceps contractile fatigue,
2. exercise stimulus,
3. dyspnea and muscle fatigue perception,
4. muscle oxygenation and cardiorespiratory demand,
and
Table 1 Acute and chronic phase description
Acute phase Chronic Phase
Patients with COPD & Healthy controls Patients with COPD
Visit 1 Visit 2 and 3* R Training Visit 4 Visit 5 and 6
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High-repetitive single limb or two
limb elastic band exercises
● CAT questionnaire † High-repetitive single












● 6MWT ● Cardiorespiratory response
● UULEX † ● Muscle oxygenation ● Exertional symptoms















Baseline measurements 8 weeks training Post assessment
*Visit order is randomized. All visits are sepearated by at least 48 h.
†Only performed by patients with COPD.
6MWT, 6-minute walk test; CAT, COPD Assessment Test; COPD, chronic obstructive pulmonary disease; RM, repetition maximum, UULEX, unsupported upper limb
exercise test.
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endurance).
Hypotheses
The following hypotheses are proposed:
1. Single-limb high-repetitive resistance training will
provide a larger gain in the 6-min walking distance
than the two-limb high-repetitive resistance training
in patients with severe to very severe (stage 3 to 4)
COPD.
2. Eight weeks of single limb high-repetitive resistance
training will be associated with larger physiological
(muscle endurance, fatigue and deoxygenation) and
structural (muscle protein synthesis, fiber-type
distribution and capillarization) adaptations to training,
and lower cardiorespiratory demand, as well a greater
increase in health-related quality-of-life in comparison
to two-limb high-repetitive resistance training.
3. Two-limb high-repetitive resistance training will
lead to larger restraints on the ventilatory system
and higher dyspnea scores and, to reduced muscle
fatigue, deoxygenation and localized exercise
stimulus in comparison to single-limb
high-repetitive resistance training in patients withCOPD. Healthy controls will be able to train both
legs/arms simultaneously without central con-
straints and with no differences in muscle fatigue
or exercise stimulus between the two high-
repetitive regimens.
Settings
The study will be performed at Institut Universitaire de
cardiologie et de pneumologie de Québec, Québec,
Canada. Recruitment and data collection will begin in
November 2014.
Sample size and eligibility criteria
A total of 30 patients will be included. This sample size
was calculated with the premises that 13 patients in each
group would be required to obtain sufficient power to
detect a 34-m (±30) between-group difference in the
6-minute walk test (6MWT), α = 0.05, β = 0.20 (80%
power), and a two-tailed test of significance, based on the
previous study on high-repetitive resistance training in
COPD [14]. We are aiming to detect at least a 30-m differ-
ence between the two groups since this value is consid-
ered to be clinically significant in this population
[21]. Considering a 15% drop-out rate in this type of
study, a total of 30 patients will be recruited. In
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size of 11 patients with COPD and 11 controls is required
to detect a relevant mean difference of 11% (±9) in limb
muscle contractile fatigue between single-limb and two-
limb execution of the exercises performed in the acute
phase of this protocol for an α = 0.05, β = 0.20 (80%
power), and a two-tailed test of significance based on a
study by Rossman et al. comparing single-leg to two-leg
knee extension in healthy adults [22].
Inclusion criteria (chronic obstructive pulmonary disease)
The inclusion criteria for participation in the trial are as
follows:
1. age ≥ 40 years,
2. cumulative (current or previous) smoking history > 10
pack-years, and
3. postbronchodilator FEV1 ≥ 50% predicted Global
Initiative for Chronic Obstructive Lung Disease
Spirometric stage 3 or 4 [4].
Exclusion criteria
The exclusion criteria for participation in the trial are as
follows:
1. recent COPD exacerbation (< 6 weeks),
2. neuromuscular and/or orthopedic disorders that
compromise participation to an exercise program,
3. recent cancer,
4. unstable cardiac disease and cardiac stimulator,
5. asthma (current),
6. low body weight or obesity (body mass index < 20
kg/m2 or > 30 kg/m2),
7. significant hypoxemia at rest (SpO2 < 85%), or
8. a daily dose > 10 mg of systemic prednisone.
Inclusion criteria (healthy controls)
The inclusion criteria for healthy controls are as follows:
1. age ≥ 40 years and
2. normal pulmonary function.
Exclusion criteria (healthy controls)
The exclusion criteria for participation as a healthy con-
trol are as follows:
1. neuromuscular and/or orthopedic disorders
compromising participation to an exercise
program or
2. physically active (> 9) on the Voorips questionnaire [23].
Description of intervention and control groups
Patients with COPD will be randomized to either single or
two-limb high-repetitive resistance training. Identicalhigh-repetitive resistance exercise regimen will be used for
both interventions, with one exception; the intervention
group will perform the exercise regimen using a single
limb at a time while the control group will, depending
on exercise, perform the training using either both
arms or both legs. A total of three sets will be per-
formed for each limb. Training time will be shorter for
the two-limb high-repetitive training group in compari-
son to the single-limb training group. To minimize any
confounding effects of different amount of time spent
with research staff, the control group will perform
a light intensity balance exercise that will compensate
for the difference in training time between the two
interventions.
Both interventions will be provided on the basis of
three sessions per week for 8 weeks. They will be
performed under direct supervision, individually or in
small groups of 2 to 4 participants. The care provider
supervising the training will receive standardized edu-
cation before the start of intervention consisting of
written, oral and visual instructions on how to perform
and instruct the exercises used in both high-repetitive
protocols.
Before the actual training, there will be a 5-minute
warm-up period on a stationary cross-trainer, focusing
on muscle groups that will be trained during various
exercises, including the latissimus row (m. latissimus
dorsi), chest press (m. pectoralis major and m. deltoid
anterior), knee extension (m. quadriceps), shoulder
flexion (m. deltoid anterior), leg curl (m. hamstrings),
elbow flexion (m. biceps brachii) and plantar flexion
(mm. triceps surae). All exercises will be performed
with elastic bands (Thera-Bands, The Hygenic Corpor-
ation 1245 Home Ave. Akron, OH 44310) with the ex-
ception of plantar flexion that will be executed using a
weight-machine (Sport Art Fitness, Woodinville, WA,
USA). Extended description of the exercise programs
for the single-limb and the two-limb group including
detailed including illustrations of start and end posi-
tions as well as execution of exercise movement is ex-
plained more in detail in the additional files [see
Additional file 1 and 2].
Unilateral or bilateral exercises with high repetitions
and low amount of rest (one minute) are selected for
this trial in line with recommendations from the
ACSM [10]. Moderate to fast velocities is recom-
mended when performing a larger number of repeti-
tions, that is, at least 15 repetitions. Participants will
be positioned so that the elastic band(s) are stretched
100% at end of movement for each exercise, respect-
ively. Since the most clinically effective portion of
elastic resistance is 25% to 250% elongation, all exer-
cise start and stop positions are within this interval
[24]. The relaxed length of the elastic resistance bands
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pre-stretched 20 times to stabilize the material [25].
Individual starting resistance will be set at 25 repeti-
tion maximum (25 RM) in the different exercises. The
resistance for each exercise and the progression of resist-
ance will be individually determined. Progression will be
done separately for the different exercises in accordance
to ACSM recommendations [10]. That is, a participant
performing >30 repetitions will result in an increase in re-
sistance. The criteria for progression should be fulfilled in
two subsequent sessions or two out of three successive
sessions. Resistance will be increased with approximately
10% by changing the tension of the resistance bands or
adding weights to the weight machine [10].
Cool down/stretching will consist of four stretching
exercises for involved muscle groups. Holding each
stretch 30 seconds to mild discomfort, two sets for each
limb (that is, two minutes of active stretching for each
muscle), in accordance to American College of Sports
Medicine recommendations [26].
Procedure
Participants will perform three visits for the acute phase
of the protocol. These visits are also used as baseline
testing for patients with COPD who will contribute to
the chronic phase of the protocol. The same evaluation
will also be performed after the 8-week training program
in patients with COPD. Pre- and post-tests will be per-
formed at similar time of day, with the same rest be-
tween test occasions and between tests.
Since a subject’s motivation may determine attainment
of maximal effort [5], both pre- and post-tests are per-
formed using standardized information and encourage-
ment [27]. No additional follow-up other than directly
after end of intervention period is used within this trial.
The perception of dyspnea and muscle fatigue will be
measured with the modified Borg scale [28] before and
directly after all physical tests as commonly and reliably
used in patients with COPD [29,14,30].
Screening tests
During the first visit, all procedures will be explained
and the informed consent form will be reviewed and
signed. Participants will then fill the Voorips physical
activity level questionnaire that is validated for elderly
individuals [23] and applied to patients with COPD [31].
Participants will complete pulmonary function assessment
(plethysmography, spirometry) while being on their usual
bronchodilator therapy. Anthropometric measurements
will include height, weight, body composition and thigh
subcutaneous skinfold. The latter is relevant for measure-
ment of muscle oxygenation. Body composition will be
assessed by bioelectrical impedance (InBody520, Body
Composition Analyzer, Biospace, Seoul, Korea).Outcome measures
Functional tests
The 6MWT will be used to assess the primary outcome,
walking distance [32]. The walking course will be 30 me-
ters in length, and the patients will be instructed in ac-
cordance to standardized guidelines [33] to walk as far
as possible in 6 minutes. One practice test will be per-
formed to minimize the risk of learning effect. The high-
est walking distance of the two 6-min walks will be
chosen as baseline value.
To measure unsupported upper limb endurance
capacity the unsupported upper limb exercise test
(UULEX) will be used [34]. Participants will hold a
plastic bar (0.2 kg), at shoulder width and will be asked
to raise it from hip to the UULEX eight level chart for
one minute at each level with a cadence of 30 move-
ments per minute. If a patient reaches the highest level,
the plastic bar will be replaced by a heavier one every
minute. There are five different bar weights (0.2, 0.5, 1,
1.5, 2 Kg), and participants will continue on the highest
level until symptom limitation.Limb muscle function
Limb muscle function will be evaluated in two ways.
Muscle strength and endurance will be evaluated during
isokinetic knee extension and shoulder flexion using the
Biodex Multi-Joint System 4 (Biodex Corp., Shirley, New
York). Both knee extension and shoulder flexion will be
performed unilaterally on the self-reported dominant
side in accordance to manufacturer recommendations.
In addition, knee extension will also be performed with
both lower limbs in order to compare single to two-limb
execution. Each movement will be performed 25 con-
secutive times using maximal effort during the concen-
tric phase and relaxation during the eccentric phase.
Two different aspects of muscle function will be mea-
sured. Peak torque from the highest contraction will be
used for maximal strength and total work generated
from all contractions will be used for endurance. The
tests will be performed at an angular velocity of 60° · s−1,
which is considered ideal for evaluating muscle strength
in patients with COPD [35] and is found reliable in
endurance testing procedures [36]. Before each test, par-
ticipants will perform five submaximal contractions to
familiarize themselves with the equipment and testing
procedures, followed by 2 minutes of standardized rest
[27]. Shoulder flexion will be performed between 0° to
90° with the elbow extended and the forearm pronated.
Knee extension will be performed between 90° flexion
to maximal individual extension minus 5° to lower the
risk for a passive resistance from the hamstrings muscles.
No visual feedback is given during tests. Standardized
encouragement will be given.
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visit two and three of the acute phase and during post
assessment in the chronic phase, in the following six
resistance exercises: latissimus row, chest press, knee
extension, shoulder flexion, leg curl and elbow flexion
[37-40]. All exercises will be executed using elastic re-
sistance bands (Thera-Bands, The Hygenic Corporation,
Akron, OH, USA) and will be performed seated using
the chair of the Biodex Multi-Joint System 4 (Biodex
Corp., Shirley, New York, USA). The positioning of the
participants will be adjusted so that the elastic resistance
band(s) is stretched 100% at end of movement. During
one visit all exercises will be performed once using one
limb at a time, while during the other visit, exercises will
be performed using two limbs simultaneously. The six
exercises will be performed for a total of three sets with
2 minutes of rest between exercises and one minute of
rest between sets. Participants will be instructed to con-
tract their limb with maximal effort at each repetition,
executing the maximal number of repetitions that can
be performed. Speed of movement will be standardized
to one second in the concentric phase and one second
in the eccentric phase with the use of a Metronome.
The loading in these exercises is determined from 25
RM tests performed during the first visit of the acute
phase, executed in accordance to recommended guidelines
[41]. The loadings obtained from the 25 RM tests will
also be considered start loading for the high-repetitive
resistance training regimens in the chronic phase of this
protocol.
In the acute phase and during post assessment in the
chronic phase the following physiological variables will
be measured while executing the latissimus row, chest
press, knee extension, shoulder flexion, leg curl and
elbow flexion exercises:
1. Muscle oxygenation
Muscle oxygenation will be acquired continuously
using a surface electrode from a near-infrared
spectroscopy system (NIRS) (OxiplexTS, ISS,
Champaign, USA) placed on the skin muscle
belly.
2. Cardiorespiratory response
Ventilatory and heart rate responses will be
determined using a portable gas analysis system
(Oxycon Mobile, Viasys Healthcare, Jaeger,
Germany). Minute ventilation (VE) oxygen uptake
(VO2), carbon dioxide excretion (VCO2,), heart rate
(HR), respiratory exchange ratio (RER) and pulsed
oxygen saturation (SpO2) will be monitored. Arterial
pressure and cardiac output will be noninvasively
measured by a finger photoplethysmograpy device
(BMEYE, Nexfin HD, Academic Medical Center,
Amsterdam, The Netherlands).3. Muscle fatigability
Isometric knee extension will be assessed in two
ways, first, by measuring the maximum voluntary
isometric contraction (MVC), and second, by
measuring supramaximal twitch tension (TW) from
a series of twitch induced by magnetic stimulation of
the femoral nerve (Magstim 200 monopulse Bistim;
Magstim Co. Ltd., Whitland, Dyfed, Wales, UK). The
occurrence of quadriceps fatigue induced by the
exercise regimens will be quantified by measuring the
fall in both MVC and TW 15 min after the high-
repetitive resistance exercises. Exertional symptoms,
that is, perceived dyspnea and muscle fatigue will be
quantified with the modified Borg scale.
4. Exercise stimulus
The exercise stimulus will be quantified from the
product of the number of repetitions and the
training load. The area under the curve of the
tension generated with the elastic bands over time of
muscle contractions will also be calculated (BioPac
Acknowledge software).
Muscle adaptation
A needle biopsy of the vastus lateralis, performed as de-
scribed by Bergström and routinely done in our laboratory
will be obtained before and after the 8-week intervention
to investigate muscle adaptation to training (key proteins
of IGF-1/PI3/AKT pathway, FOXOs, MuRF and MABx/
atrogin, fiber-type distribution, enzymatic activities and
capillarization).
Quality of life and feasibility
Quality of life will be determined with the COPD As-
sessment test (CAT) [42] and the feasibility of the exer-
cise regimens will be assessed by compliance (number of
attended training session) and progression of intensity.
The occurrence and severity of any adverse events will
be recorded.
Randomization and blinding
To prevent foreknowledge of treatment assignment and
to keep the allocation sequence concealed from the par-
ticipants and the researchers, group allocation will be
done after the completion of baseline and inclusion tests
by an individual independent of the recruitment process
using a randomly permuted blocks design with a com-
puter random number generator. Randomization will be
performed with a 1:1 allocation to the intervention or
control group. The allocation sequence will be kept in
an opaque, sealed and stapled envelope and will be kept
concealed until end of outcome assessment. The enve-
lope will be made impermeable to intense light by using
aluminum foil inside and sealed using tamper-proof la-
bels. Furthermore, the participants will be given repeated
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outcome assessors. In case of failure in keeping the
outcome assessor blinded (that is, a patient reveals his/her
group allocation), a second trained outcome assessor will
be available.
Statistics
The analysis of primary and secondary outcome mea-
surements will include all randomized patients analyzed
by their original group in accordance with intention-to-
treat. Within group and between group changes will be
analyzed using linear mixed models. In addition, within
the main analysis, an on-treatment analysis will be per-
formed. On-treatment is defined as at least 75% compli-
ance, in other words at least 18 training sessions. Mixed
models will be used to handle missing outcome data.
For comparison of single and two limb exercises student
t-tests will be performed. A level of 0.05 will be consid-
ered valid for statistical significance. For data manage-
ment and statistical analysis the IBM Statistical package
for Social Science (SPSS) version 21.0 will be used.
Ethical approval and informed consent
The study has been approved by the Ethical Board of the
Institut universitaire de cardiologie et de pneumologie
de Québec: CER 21111. All participants will receive brief
and comprehensible oral and written information in ac-
cordance to the Helsinki declaration [43]. Informed,
written consent is obtained from all participants before
baseline testing.
Discussion
The prevention of limb muscle dysfunction in patients
with COPD is considered of utmost importance [3].
However, the progressive increase in dyspnea during ex-
ercise training that is common in COPD [44] may limit
patient’s ability to achieve optimal exercise stimulus
since it causes premature exercise limitation [11,12].
The origin of exertional dyspnea has been considered
multifactorial [44], involving hyperinflation, increased
work of breathing and inadequate energy supply to re-
spiratory and limb muscles as well as intrinsic limb
muscle dysfunction [45-48].
High-repetitive single limb resistance training, if com-
pared to a control, may increase limb muscle function and
functional exercise capacity in patients with COPD while
minimizing the occurrence of limiting exertional symp-
toms [17,14]. However, no comparison to another exercise
regimen has been performed and the intramuscular effects
and mechanism of action of this exercise training regimen
remain unclear. The proposed trial will give new know-
ledge to this research area by investigating the mecha-
nisms and effects of single limb exercises in comparison
to exercises incorporating a larger amount of muscle massin patients with COPD and healthy individuals. The use of
a single limb approach is novel in patients with COPD,
and only a few studies have been published on the topic
[13,49,15,17,14]. Most studies have focused on aerobic ex-
ercises and in only one study was resistance training the
main training modality [17,14]. The results from the pro-
posed trial will provide further insights in the field of sin-
gle limb training by 1) thoroughly assessing dyspnea and
muscle specific responses in both upper and lower limbs
during and after high-repetitive resistance training in pa-
tients with COPD; 2) investigating mechanisms of im-
provement behind single upper and lower limb elastic
band resistance training; 3) examining acute effects of
upper and lower limb single limb elastic band resistance
training exercises; and 4) exploring muscle fatigability and
the cardiorespiratory demand during such exercises. Acute
effects and responses to exercise training have been inves-
tigated using comprehensive protocols and equipment
that may not be suitable in clinical settings. The present
project will assess the acute response to training using
elastic bands, which should be widely available [17,14].
Furthermore, since both upper and lower limb muscles are
impaired in patients with COPD and since the local effects
of exercise training only occur in involved muscle, the
incorporation of both upper and lower limbs is of great
interest [13,49,15]. One ultimate goal is to learn how to
optimize the effects of exercise training and how to
customize the interventions in COPD. If, as we hypothesize,
single-limb high-repetitive resistance training produces
more fatigue and less dyspnea and as a result larger physio-
logical adaptations than exercise involving larger muscle
groups, this project may eventually influence how patients
with COPD are trained. The results of this project will
provide novel information that should be instrumental in
individualizing patients’ treatment in a way that could be
easily implemented in clinical practice.
Trial registration
The clinical trial was registered before the enrollment of the
first participant. Date of trial registration: 4 November 2014.
The first participant was randomized on 10 November 2014.
ClinicalTrials.gov identifier: NCT02283580. Trial registra-
tion has been based on the WHO registration advisory
group minimal registration set [50].
Trial status
The trial was recruiting participants at the time of sub-
mission of this protocol 06 January 2015.
Additional files
Additional file 1: Exercise program single-limb group. Description of
data: Detailed description of exercise program (warm-up, exercises and
stretching) for single-limb group including illustrations of start and end
Nyberg et al. Trials  (2015) 16:194 Page 9 of 10positions and muscles involved in each exercise. Information on number
of sets, repetitions in each set, rest, speed of movement and execution of
exercise movements.
Additional file 2: Exercise program two-limb group. Description of
data: Detailed description of exercise program (warm-up, exercises and
stretching) for two-limb group including illustrations of start and end
positions and muscles involved in each exercise. Information on number
of sets, repetitions in each set, rest, speed of movement and execution of
exercise movements.
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